Maïlys Ferrère

Discovers, develops and commercializes novel HDL therapies for the treatment of cardiovascular and metabolic diseases

Functions as a College/University

BPIfrance Investissement is an active manager focused on small, medium and intermdiate-sized businesses with high-growth potential. They favor sectors related to industry and technology and focus on investments in France. The firm invests either directly through dedicated investment funds or indirectly through private equity funds, partnerships and fund of funds managed by third parties. They invest across development stages, from start-ups to small LBO operations resulting from corporate succession issues. Their deal-sourcing process is both regional and national.

Manufactures fine and agro chemicals & biopharmaceuticals products

Acts as Private Equity Fund

BPIfrance Participations PE is an active, medium-term manager which aims to support small,medium and intermediate-sized French companies with growth potential, particularly in technology-related sectors. They also invest in large companies with liquidity issues and may exceptionally consider investing directly in seed and start-up companies. The firm targets companies with strong products and significant long-term sales potential which are facing short-term balance sheet difficulties. Their key investment criteria include viability and profitability. They get actively involved in strategic decisions, encourage the R&D activity within their investee companies, and promote social and environmental responsibility. BPIfrance Participations PE invests primarily in the form of direct equity, possibly complemented with near equity, convertible debt and warrants. They typically take minority stakes and favor co-investing with public or private sector partners, including foreign investors. They consider investments across sectors within the real economy, such as technology, industrials and services. They avoid financials, real estate, retail and non-competitive activities. The firm's exit horizon and strategy are flexible and take into account the time requirements of the R&D process as well as the state of the economy.

Develops audio integrated amplifiers

Develops and commercializes of prophylactic vaccines for infectious diseases

Operates as a bioelectronics company that develops bionic vision systems

Manufactures and markets novel therapies for severe retinal neurodegenerative diseases

Sovereign wealth fund

Develops software tools and applications for healthcare professionals

Functions as an investment holding company